文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

The extent of oesophageal acid exposure overlap among the different gastro-oesophageal reflux disease groups.

作者信息

Shapiro M, Green C, Faybush E M, Esquivel R F, Fass R

机构信息

The Neuro-Enteric Clinical Research Group, Section of Gastroenterology, Department of Medicine, Southern Arizona VA Health Care System and University of Arizona Health Sciences Center, Tucson, AZ 85723-0001, USA.

出版信息

Aliment Pharmacol Ther. 2006 Jan 15;23(2):321-9. doi: 10.1111/j.1365-2036.2006.02747.x.


DOI:10.1111/j.1365-2036.2006.02747.x
PMID:16393313
Abstract

BACKGROUND: Studies have demonstrated that patients with Barrett's oesophagus have the highest oesophageal acid exposure profile, followed by erosive oesophagitis and non-erosive reflux disease patients, but the exact extent of overlap remains unknown. AIM: To determine the extent of overlap in oesophageal acid exposure among the different gastro-oesophageal reflux disease groups. METHODS: A total of 121 patients with gastro-oesophageal reflux disease underwent an upper endoscopy and were classified as having Barrett's oesophagus, erosive oesophagitis and non-erosive reflux disease-all (non-erosive reflux disease-positive and functional heartburn). Subsequently, patients underwent pH testing and overlap in oesophageal acid exposure among the different gastro-oesophageal reflux disease groups was determined. RESULTS: Of those enrolled, 24 had Barrett's oesophagus, 30 erosive oesophagitis and 28 were non-erosive reflux disease-positive. Mean oesophageal acid exposure time was 224.8 +/- 35, 134.3 +/- 21.9 and 141.3 +/- 19.8 min for Barrett's oesophagus, erosive oesophagitis and non-erosive reflux disease-positive respectively. Per cent overlap for total, upright and supine time between non-erosive reflux disease-positive and erosive oesophagitis was 47.4%, 64.7% and 81.8%, between Barrett's oesophagus and erosive oesophagitis was 47.8%, 40.7% and 24%, and between Barrett's oesophagus and non-erosive reflux disease-positive was 31.6%, 37.5% and 20.8% respectively. CONCLUSIONS: Our study demonstrated a high oesophageal acid exposure overlap between patients with non-erosive reflux disease-positive and erosive oesophagitis, Barrett's oesophagus and erosive oesophagitis, as well as Barrett's oesophagus and non-erosive reflux disease-positive patients.

摘要

相似文献

[1]
The extent of oesophageal acid exposure overlap among the different gastro-oesophageal reflux disease groups.

Aliment Pharmacol Ther. 2006-1-15

[2]
Pathophysiological characteristics of the various forms of gastro-oesophageal reflux disease. Spectrum disease or distinct phenotypic presentations?

Dig Liver Dis. 2006-9

[3]
Multivariate analysis of the association of acid and duodeno-gastro-oesophageal reflux exposure with the presence of oesophagitis, the severity of oesophagitis and Barrett's oesophagus.

Gut. 2008-8

[4]
Oesophageal and gastric pH profiles in patients with gastro-oesophageal reflux disease and Barrett's oesophagus treated with proton pump inhibitors.

Aliment Pharmacol Ther. 2004-9-15

[5]
Comparisons of the distribution of oesophageal acid exposure throughout the sleep period among the different gastro-oesophageal reflux disease groups.

Aliment Pharmacol Ther. 2007-7-1

[6]
Does Barrett's oesophagus develop over time in patients with chronic gastro-oesophageal reflux disease?

Aliment Pharmacol Ther. 2007-1-1

[7]
Non-erosive reflux disease (NERD)--acid reflux and symptom patterns.

Aliment Pharmacol Ther. 2003-2-15

[8]
Cytokeratin 7 and 20 expression in intestinal metaplasia of the distal oesophagus: relationship to gastro-oesophageal reflux disease.

Histopathology. 2005-9

[9]
[Quantification of gastro-esophageal reflux in Barrett's esophagus].

Rev Esp Enferm Dig. 1990-3

[10]
Relationship between gastro-oesophageal reflux pattern and severity of mucosal damage.

Neurogastroenterol Motil. 2009-8

引用本文的文献

[1]
Drug treatment strategies for erosive esophagitis in adults: a narrative review.

Transl Gastroenterol Hepatol. 2025-7-23

[2]
Reflux-Related Abnormalities at Distal oesophagus, Gastric Pouch and Anastomotic Site 4 Years After OAGB: Diagnostic Accuracies of Endoscopy Compared to Biopsy and of Symptoms Compared to Both.

Obes Surg. 2025-4

[3]
Variation in Fatty Acid Synthase, Ki67 and p53 Esophageal Mucosa Expressions in Barrett's Esophagus Patients Treated for One Year with Two Esomeprazole Different Regimens.

Curr Issues Mol Biol. 2023-5-29

[4]
Local inflammatory response to gastroesophageal reflux: Association of gene expression of inflammatory cytokines with esophageal multichannel intraluminal impedance-pH data.

World J Clin Cases. 2022-9-16

[5]
Distinction between patients with non-erosive reflux disease and functional heartburn.

Ann Gastroenterol. 2013

[6]
Current advances in the diagnosis and treatment of nonerosive reflux disease.

Gastroenterol Res Pract. 2013-7-11

[7]
Barrett's esophagus and the risk of obstructive sleep apnea: a case-control study.

BMC Gastroenterol. 2013-5-11

[8]
Outcomes in patients with nonerosive reflux disease treated with a proton pump inhibitor and alginic acid ± glycyrrhetinic acid and anthocyanosides.

Clin Exp Gastroenterol. 2013

[9]
NERD: an umbrella term including heterogeneous subpopulations.

Nat Rev Gastroenterol Hepatol. 2013-3-26

[10]
A randomized open-label trial of on-demand rabeprazole vs ranitidine for patients with non-erosive reflux disease.

World J Gastroenterol. 2012-5-21

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索